Alkem Laboratories Limited
ALKEM
Rangering i aksjer
#2813
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aksjekurs
$55.19
Markedsverdi
$6.60B
Endring (1 dag)
-0.06%
Endring (1 år)
-12.43%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
Antall utestående aksjer for Alkem Laboratories Limited (ALKEM)
Antall utestående aksjer per June 2026: 119.57M
Ifølge Alkem Laboratories Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 119.57M. Ved slutten av March 2024 hadde selskapet 119.57M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Alkem Laboratories Limited (ALKEM) fra 2010 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 119.57M | 0.00% |
| 2025 | 119.57M | 0.00% |
| 2024 | 119.57M | 0.00% |
| 2023 | 119.57M | 0.00% |
| 2022 | 119.57M | 0.00% |
| 2021 | 119.57M | 0.00% |
| 2020 | 119.57M | 0.00% |
| 2019 | 119.57M | 0.00% |
| 2018 | 119.57M | 0.00% |
| 2017 | 119.57M | 0.00% |
| 2016 | 119.57M | 0.00% |
| 2015 | 119.57M | 0.00% |
| 2014 | 119.57M | 0.00% |
| 2013 | 119.57M | 0.00% |
| 2012 | 119.57M | 0.00% |
| 2011 | 119.57M | -0.01% |
| 2010 | 119.58M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,906.72% |
IN
|
